name: OXYBENZONE 40 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / HOMOSALATE 130 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL LOTION [Leader Baby SPF 50]


name: OCTINOXATE 75 mg in 1 g / OXYBENZONE 50 mg in 1 g TOPICAL LIPSTICK [Neutrogena Revitalizing Lip Balm SPF 20 - Fresh Plum 60]


name: TITANIUM DIOXIDE 2.05 mg in 50 mL / ZINC OXIDE 5.75 mg in 50 mL TOPICAL CREAM [Dr.Jart Every Sun Day Mineral Sun Screen]


name: ZINC OXIDE 240 mg in 1 mL TOPICAL LOTION [MUSTELA MINERAL SUNSCREEN BROAD SPECTRUM SPF 50]


name: BASIC FIBROBLAST GROWTH FACTOR (HUMAN) 0.001 g in 100 mL TOPICAL LIQUID [Oliglo Multi-Action Peptide Gel Pack]


name: GREEN TEA LEAF 1.2 g in 100 mL TOPICAL LIQUID [Oliglo Lifting Serum]


name: HOMOSALATE 50 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OXYBENZONE 20 mg in 1 mL / TITANIUM DIOXIDE 29 mg in 1 mL TOPICAL LOTION [Neutrogena Healthy Skin Radiant Tinted Moisturizer Sunscreen Broad Spectrum SPF 30, Sheer Ivory 10]


name: TITANIUM DIOXIDE 15 g in 100 g / ZINC OXIDE 10 g in 100 g TOPICAL POWDER [Super BB Beauty Balm Powder SPF 30]


name: TITANIUM DIOXIDE 57.6 mg in 1 mL / ZINC OXIDE 29.4 mg in 1 mL TOPICAL CREAM [Super BB Beauty Balm Cream SPF 30]


name: AVOBENZONE 27 mg in 1 mL / HOMOSALATE 40 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL / OXYBENZONE 45 mg in 1 mL TOPICAL LOTION [Neutrogena Clear Face Breakout Free Oil Free Broad Spectrum SPF 55]


name: ZINC OXIDE 25 g in 100 g TOPICAL CREAM [Bali Bloc SPF 30 Cocoa Sunscreen]


name: OCTINOXATE 562 mg in 1 g / OCTISALATE 250 mg in 1 g / ZINC OXIDE 1000 mg in 1 g / OCTOCRYLENE 1000 mg in 1 g TOPICAL CREAM [Sunscreen]


name: TITANIUM DIOXIDE 15 g in 100 g / ZINC OXIDE 10 g in 100 g TOPICAL POWDER [Mineral Wear Airbrushing Pressed Powder]


name: ZINC OXIDE 25 g in 100 g TOPICAL CREAM [Green Screen SPF 31 Bronze Sunscreen]


name: AVOBENZONE 90 mg in 1 g / HOMOSALATE 225 mg in 1 g / OCTISALATE 250 mg in 1 g / OCTOCRYLENE 1000 mg in 1 g TOPICAL SPRAY [Sunscreen]


name: TITANIUM DIOXIDE 6.388 mg in 40 mL / OCTINOXATE 1.996 mg in 40 mL / OCTISALATE 1.2 mg in 40 mL TOPICAL CREAM [Dr.Jart Dis-A-Pore Beauty Balm 01]


name: TITANIUM DIOXIDE 6.388 mg in 40 mL / OCTINOXATE 1.996 mg in 40 mL / OCTISALATE 1.2 mg in 40 mL TOPICAL CREAM [Dr.Jart Dis-A-Pore Beauty Balm 02]


name: TITANIUM DIOXIDE 10 mg in 1 mL / ZINC OXIDE 200 mg in 1 mL TOPICAL CREAM [ZO Skin Health Sunscreen Plus Primer Broad-Spectrum SPF 30]


name: CIPROFLOXACIN HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: Benzalkonium Chloride;Lidocaine/Prilocaine 0.13%; 2.5%-2.5% Topical application Kit [MICROVIX LP]


name: Zinc Oxide 200 mg in 1 g TOPICAL CREAM [CoTZ Flawless Complexion]


name: Zinc Oxide 200 mg in 1 g TOPICAL CREAM [TiZO Ultra Zinc SPF 40 (Tinted)]


name: OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL LOTION [Hand Screen Broad Spectrum Sunscreen SPF 40]


name: DICLAZURIL 1 g in 1 g NOT APPLICABLE POWDER


name: IDOXURIDINE 1 g in 1 g NOT APPLICABLE POWDER


name: OCTINOXATE 1.6611 g in 30 mL / TITANIUM DIOXIDE 0.8475 mg in 30 mL TOPICAL EMULSION [CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION O70]


name: OCTOCRYLENE 2 g in 100 g / AVOBENZONE 1 g in 100 g TOPICAL LOTION [Hawaiian Tropic Island Tanning Sunscreen Cocoa Butter SPF 4]


name: OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL CREAM [AMBI SKINCARE Even and Clear Daily Facial Moisturizer SPF 30]


name: Octinoxate 75 mg in 1 g / Octisalate 50 mg in 1 g / Oxybenzone 30 mg in 1 g / Titanium Dioxide 67.4 mg in 1 g TOPICAL CREAM [COVER plus CORRECT/TINTED MOISTURIZER CC CRM FAIR]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 15 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 8 g in 100 g TOPICAL SPRAY [TRADER JOES SUNSCREEN SPF 50]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 7 g in 100 mL TOPICAL LOTION [TRADER JOES FACE AND BODY SUNSCREEN SPF 30]


name: Octinoxate 0.065 g in 1 g / Titanium Dioxide 0.0244 g in 1 g / Zinc Oxide 0.0157 g in 1 g TOPICAL PASTE [LBEL MOUSSE MATIFFIANT MATTE FINISH MOUSSE FOUNDATION SPF 15 Claire 1/Beige]


name: Octinoxate 0.065 g in 1 g / Titanium Dioxide 0.0244 g in 1 g / Zinc Oxide 0.0157 g in 1 g TOPICAL PASTE [LBEL MOUSSE MATIFFIANT MATTE FINISH MOUSSE FOUNDATION SPF 15 Claire 2/ Beige]


name: Octinoxate 0.065 g in 1 g / Titanium Dioxide 0.0244 g in 1 g / Zinc Oxide 0.0157 g in 1 g TOPICAL PASTE [LBEL MOUSSE MATIFFIANT MATTE FINISH MOUSSE FOUNDATION SPF 15 Claire 3/ Beige]


name: Octinoxate 0.065 g in 1 g / Titanium Dioxide 0.0244 g in 1 g / Zinc Oxide 0.0157 g in 1 g TOPICAL PASTE [LBEL MOUSSE MATIFFIANT MATTE FINISH MOUSSE FOUNDATION SPF 15 Claire 4/ Beige]


name: Zinc Oxide 200 mg in 1 g TOPICAL CREAM [CoTZ Baby]


name: GLYCERIN 2 g in 100 mL TOPICAL LOTION [Zenibell Snail Intensive]


name: AVOBENZONE 90 mg in 1 mL / HOMOSALATE 1000 min in 1 mL / OCTISALATE 202.5 mg in 1 mL / OCTOCRYLENE 640 mg in 1 mL TOPICAL LOTION [Sunscreen]


name: OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 6 g in 100 g / HOMOSALATE 7 g in 100 g / AVOBENZONE 2.7 g in 100 g TOPICAL OIL [Hawaiian Tropic Island Tanning Broad Spectrum SPF 25]


name: Zinc Oxide 200 mg in 1 g TOPICAL CREAM [CoTZ Sensitive]


name: LIDOCAINE 10 mg in 1 mL TOPICAL OINTMENT [Prolayed Lidocaine Male Genital Desensitizer]


name: OCTOCRYLENE 6.5 g in 100 g / AVOBENZONE 2.7 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL LOTION [Banana Boat Ultra Sport Sunscreen Broad Spectrum SPF 50]


name: LOSARTAN POTASSIUM 1 g in 1 g NOT APPLICABLE POWDER


name: OCTINOXATE 7 g in 100 g / TITANIUM DIOXIDE 7.6 g in 100 g / ZINC OXIDE 3.6 g in 100 g TOPICAL CREAM [TOM FORD SHADE AND ILLUMINATE FOUNDATION BROAD SPECTRUM SPF 45 SOFT RADIANCE CUSHION COMPACT REFILL]


name: OCTOCRYLENE 3 g in 100 g / OXYBENZONE 4 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / AVOBENZONE 3 g in 100 g TOPICAL SPRAY [Hawaiian Tropic Silk Hydration Clear Sunscreen Broad Spectrum SPF 50]


name: AVOBENZONE 90 mg in 1 mL / HOMOSALATE 2250 mg in 1 mL / Octisalate 250 mg in 1 mL / OCTOCRYLENE 1000 mg in 1 mL TOPICAL lotion [SUNSCREEN]


name: GLYCERIN 2 g in 100 g TOPICAL CREAM [Zenibell Snail IntensiveCream]


name: GLYCERIN 2 g in 100 mL TOPICAL LIQUID [Zenibell Snail Intensive Toner]


name: PETROLATUM 86 mg in 1 g TOPICAL OINTMENT [Resurfix Plus]


name: Avobenzone 90 g in 1 g / Homosalate 2250 g in 1 g / Octisalate 250 g in 1 g / Octocrylene 640 g in 1 g TOPICAL SPRAY [sunscreen]


name: syringe with needle,insulin,0.5 mL 32 gauge X 5/16" MISCELL SYRINGE, EMPTY DISPOSABLE


name: allantoin / benzocaine / camphor / dimethicone / menthol / petrolatum


name: CATHETER,INTERMITTENT 18FR LOFRIC HYDRO-KIT #4201840


name: CATHETER,INTERMITTENT COUDE 12FR LOFRIC PRIMO #4151240


name: CATHETER,INTERMITTENT,GENTLECATH 16FR FEMALE #501023


name: FEEDING BAG W/PUMP SET ENFIT COVIDIEN #772055


name: Medical Dictionary for Regulatory Activities Terminology (MedDRA), Korean Edition


name: Regurgitant blood flow pressure half-time


name: Gene product metabolic activity interpretation


name: IRF-PAI v3.0, LCDS v4.00, OASIS E - Health conditions - discharge or expired or transfer


name: LCDS v4.00 - Signs and Symptoms of Delirium (from CAM)


name: LCDS v4.00 - Self-care - discharge performance


name: LCDS v3.00 - Bladder and bowel - planned discharge


name: LCDS v4.00 - Self-care - admission performance


name: LCDS v4.00 - Skin conditions - discharge


name: LCDS v4.00 - Spontaneous breathing trial


name: MDS v3.0 - RAI v1.17.2 - Optional state assessment


name: Outcome and assessment information set (OASIS) form - version D1:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D1


name: OASIS D1 - Patient history and diagnoses - follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS D1 - Patient history and diagnoses - follow-up


name: OASIS D1 - ADL and IADLs - follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D1 - Follow-up - recertification or other follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D1 - Follow-up - recertification or other follow-up


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the effect of ongoing health problems such as high blood pressure or diabetes on your pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the effect of ongoing health problems such as high blood pressure or diabetes on your pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about feeling tired and having low energy during your pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about feeling tired and having low energy during your pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for your medical care during pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for your medical care during pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your weight and body shape during pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your weight and body shape during pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether you might have an unhealthy baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether you might have an unhealthy baby


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting:Find:Pt:^Patient:Ord:NuMoM2b


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as swollen feet:Find:Pt:^Patient:Ord:NuMoM2b


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as swollen feet


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as backaches:Find:Pt:^Patient:Ord:NuMoM2b


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as backaches


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the quality of your medical care during pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the quality of your medical care during pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working or caring for your family during your pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working or caring for your family during your pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might be affected by alcohol, cigarettes, or drugs that you have taken:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might be affected by alcohol, cigarettes, or drugs that you have taken


name: Are there other things that you are bothered, upset or worried about that have to do with your pregnancy, the birth, or the baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are there other things that you are bothered, upset or worried about that have to do with your pregnancy, the birth, or the baby


name: Other things you are feeling bothered, upset or worried about:Find:Pt:^Patient:Nom:NuPDQ


name: Other things you are feeling bothered, upset or worried about


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for the baby's clothes, food, or medical care:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for the baby's clothes, food, or medical care


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about taking care of a newborn baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about taking care of a newborn baby


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about pain during labor and delivery:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about pain during labor and delivery


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might come too early:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might come too early


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting, swollen feet, or backaches:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting, swollen feet, or backaches


name: Physical symptom of pregnancy that you are feeling bothered, upset or worried about:Find:Pt:^Patient:Nom:NuPDQ


name: Physical symptom of pregnancy that you are feeling bothered, upset or worried about


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby


name: Person who you are feeling bothered, upset or worried about having a relationship change with due to having a baby:Find:Pt:^Patient:Nom:NuPDQ


name: Person who you are feeling bothered, upset or worried about having a relationship change with due to having a baby


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about what will happen during labor and delivery:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about what will happen during labor and delivery


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working at a job after the baby comes:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working at a job after the baby comes


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about getting day care, babysitters, or help to watch the baby after it comes:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about getting day care, babysitters, or help to watch the baby after it comes


name: Revised Prenatal Distress Questionnaire - Concurrent Self-Administered Version:-:Pt:^Patient:-:NuPDQ


name: Revised Prenatal Distress Questionnaire - Concurrent Self-Administered Version


name: Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-Be Difficulties in Pregnancy form:-:Pt:^Patient:-:NuMoM2b


name: Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-Be Difficulties in Pregnancy form


name: Quality of Working Life Questionnaire for Cancer Survivors:-:4W:^Patient:-:QWLQ-CS


name: Quality of Working Life Questionnaire for Cancer Survivors


name: During the past 4W, working gives me structure in my life:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, working gives me structure in my life


name: During the past 4W, I think it is good to work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I think it is good to work


name: During the past 4W, I consider that my work gives me a goal in life:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I consider that my work gives me a goal in life


name: During the past 4W, I consider my work important:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I consider my work important


name: During the past 4W, I do my work well:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am self-confident in my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am self-confident in my work


name: During the past 4W, I am suited to my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am suited to my work


name: During the past 4W, I have control over the work I do:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have control over the work I do


name: During the past 4W, I feel powerless in my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I feel powerless in my work


name: During the past 4W, I feel there is a positive atmosphere in my working environment:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I feel there is a positive atmosphere in my working environment


name: During the past 4W, I have the feeling I am taken seriously by people in my working environment:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have the feeling I am taken seriously by people in my working environment


name: During the past 4W, I am content with my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am content with my work


name: During the past 4W, I have good relations with my colleagues:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have good relations with my colleagues


name: During the past 4W, I feel valuable to my colleagues:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I feel valuable to my colleagues


name: During the past 4W, my immediate superior understands my health situation and possible health problems:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, my immediate superior understands my health situation and possible health problems


name: During the past 4W, I have good relations with my immediate superior:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have good relations with my immediate superior


name: During the past 4W, I consider that employees with health problems are treated well in my organization:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I consider that employees with health problems are treated well in my organization


name: During the past 4W, I am content with the fringe benefits provided by my employer:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am content with the fringe benefits provided by my employer


name: During the past 4W, I am content with my current income:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am content with my current income


name: During the past 4W, because of my health situation I have problems in my work with fatigue AndOr lack of energy:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, because of my health situation I have problems in my work with fatigue AndOr lack of energy


name: During the past 4W, I am limited in my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am limited in my work


name: During the past 4W, because of my health situation I have little trust in my own body:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, because of my health situation I have little trust in my own body


name: During the past 4W, because of my health situation I feel uncertain about the future:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, because of my health situation I feel uncertain about the future


name: Perception of your work situation:-:4W:^Patient:-:QWLQ-CS


name: Atmosphere in your working environment:-:4W:^Patient:-:QWLQ-CS


name: Understanding and recognition in your organization:-:4W:^Patient:-:QWLQ-CS


name: Understanding and recognition in your organization


name: Problems due to your health situation:-:4W:^Patient:-:QWLQ-CS


name: Difficulties in Pregnancy total score:Score:Pt:^Patient:Qn:NuMoM2b


name: Dark-mediated rod adaptation time:Time:Pt:Eye.right:Qn


name: Dark-mediated rod adaptation time:Time:Pt:Eye.left:Qn


name: New York Heart Association Functional Classification:-:Pt:^Patient:-:NYHA


name: New York Heart Association Functional Classification


name: Sit to stand^with use of upper extremities:NRat:30S:^Patient:Qn


name: Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.0:-:RptPeriod:^Patient:-:CMS Assessment


name: Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.0


name: Bone development stage:Score:Pt:Upper extremity>Radius:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.trapezoid:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.trapezium:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.scaphoid:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.lunate:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.triquetrum:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.hamate:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.capitate:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Thumb.distal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.fifth.distal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.third.distal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.third.middle phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.fifth.middle phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.fifth.proximal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.third.proximal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Thumb.proximal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Hand.metacarpal.fifth:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Hand.metacarpal.third:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Hand.metacarpal.first:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Ulna:Qn:XR


name: Drug classes that have an indication documented:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Drug classes that have an indication documented


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - High risk drug classes - use and indication:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - High risk drug classes - use and indication


name: How much of the time has pain made it hard for you to sleep at night:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy:Find:Pt:^Patient:Ord:SILS


name: How Often Need Help Reading Instructions, Pamphlets, or other Written Material from Doctor or Pharmacy


name: How often have you limited your day-to-day activities because of pain:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: How often do you feel lonely or isolated from those around you:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: How often do you feel lonely or isolated from those around you


name: How often have you limited your participation in rehabilitation therapy sessions due to pain over:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: IRF-PAI v4.0 - Administrative information:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Administrative information


name: IRF-PAI v4.0 - Cognitive patterns - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Cognitive patterns - admission


name: IRF-PAI v4.0 - Cognitive patterns - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Cognitive patterns - discharge


name: IRF-PAI v4.0 - Health conditions - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Health conditions - admission


name: IRF-PAI v4.0 - Hearing, speech, and vision - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Hearing, speech, and vision - admission


name: IRF-PAI v4.0, OASIS E - Hearing, speech, and vision - ROC, DC:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, OASIS E - Hearing, speech, and vision - ROC, DC


name: IRF-PAI v4.0 - Identification information:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Identification information


name: IRF-PAI v4.0, LCDS v5.00 - Medications - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Medications - admission


name: IRF-PAI v4.0, LCDS v5.00 - Medications - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Medications - discharge


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - Mood:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - Mood


name: IRF-PAI v4.0 - Quality indicators - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Quality indicators - admission


name: IRF-PAI v4.0 - Quality indicators - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Quality indicators - discharge


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - admission


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - discharge


name: IRF-PAI v4.0 - Swallowing &or nutritional status - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Swallowing &or nutritional status - admission


name: IRF-PAI v4.0, LCDS v5.00 - Swallowing &or nutritional status - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Swallowing &or nutritional status - discharge


name: IRF-PAI v4.0, LCDS v5.00 - Health conditions - discharge or expired:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Health conditions - discharge or expired


name: IRF-PAI v4.0, LCDS v5.00 - Nutritional approaches - last 7D and discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Nutritional approaches - last 7D and discharge


name: Provision of current reconciled medication list to patient at discharge:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Provision of current reconciled medication list to patient at discharge


name: Provision of current reconciled medication list to subsequent provider at discharge:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Provision of current reconciled medication list to subsequent provider at discharge


name: Route of current reconciled medication list transmission to patient:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Route of current reconciled medication list transmission to patient


name: Route of current reconciled medication list transmission to subsequent provider:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Route of current reconciled medication list transmission to subsequent provider


name: Special treatments, procedures, and programs at discharge:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Special treatments, procedures, and programs at discharge


name: Preferred language & interpreter need:-:Pt:^Patient:-


name: IRF-PAI v4.0 - Administrative information - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Administrative information - discharge


name: Total skeletal maturity score:Score:Pt:Upper extremity>Wrist+Hand:Qn:XR


name: TPMT gene & NUDT15 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: TPMT gene & NUDT15 gene targeted mutation analysis


name: NUDT15 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: NUDT15 gene product metabolic activity interpretation:Imp:Pt:Bld/Tiss:Ord:Molgen


name: NUDT15 gene product metabolic activity interpretation


name: Warfarin response genotype panel:-:Pt:Bld/Tiss:-:Molgen


name: Ehlers-Danlos syndrome multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Ehlers-Danlos syndrome multigene analysis


name: Coronary heart disease multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Coronary heart disease multigene analysis


name: Ventilator weaning status:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: LCDS v5.00 - Spontaneous breathing trial:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Spontaneous breathing trial


name: LCDS v5.00 - Special treatments, procedures, and programs - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Special treatments, procedures, and programs - discharge


name: LCDS v5.00 - Special treatments, procedures, and programs - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Special treatments, procedures, and programs - admission


name: LCDS v5.00 - Swallowing &or nutritional status - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Swallowing &or nutritional status - admission


name: LCDS v5.00 - Health conditions - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Health conditions - admission


name: LCDS v5.00 - Functional abilities and goals - planned discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Functional abilities and goals - planned discharge


name: LCDS v5.00 - Functional abilities and goals - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Functional abilities and goals - admission


name: LCDS v5.00 - Cognitive patterns - unplanned discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Cognitive patterns - unplanned discharge


name: Deprecated LCDS v5.00 - Cognitive patterns - planned discharge [CMS Assessment]


name: LCDS v5.00 - Cognitive patterns - planned discharge


name: LCDS v5.00 - Cognitive patterns - admission and planned discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Cognitive patterns - admission and planned discharge


name: LCDS v5.00 - Hearing, speech, and vision - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Hearing, speech, and vision - discharge


name: LCDS v5.00 - Hearing, speech, and vision - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Hearing, speech, and vision - admission


name: LCDS v5.00 - Administrative information - expired:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Administrative information - expired


name: LCDS v5.00 - Administrative information - planned discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Administrative information - planned discharge


name: LCDS v5.00 - Administrative information - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Administrative information - admission


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.00:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.00


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.00:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.00


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.00:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.00


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.00:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.00


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 5.00:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 5.00


name: LCDS v5.00 - Patient demographic information - unplanned discharge and expired:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Patient demographic information - unplanned discharge and expired


name: LCDS v5.00 - Patient demographic information - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Patient demographic information - admission


name: LCDS v5.00 - Patient demographic information - planned discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Patient demographic information - planned discharge


name: LCDS v5.00 - Administrative information - unplanned discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Administrative information - unplanned discharge


name: Coagulation dilute Russell viper venom induced^post heparin neutralization:Time:Pt:PPP:Qn:Coag


name: Coagulation surface induced.lupus sensitive^post heparin neutralization:Time:Pt:PPP:Qn:Coag


name: Coagulation surface induced.lupus sensitive.excess phospholipid^post heparin neutralization:Time:Pt:PPP:Qn:Coag


name: Coagulation surface induced.lupus sensitive.excess phospholipid actual/Normal^post heparin neutralization:RelTime:Pt:PPP:Qn:Coag


name: Coagulation dilute Russell viper venom induced.excess phospholipid^post heparin neutralization:Time:Pt:PPP:Qn:Coag


name: Coagulation dilute Russell viper venom induced.excess phospholipid actual/normal^post heparin neutralization:RelTime:Pt:PPP:Qn:Coag


name: Coagulation dilute Russell viper venom induced.factor substitution^immediately after 1:1 addition of normal plasma+heparin neutralization:Time:Pt:PPP:Qn:Coag


name: Columbia - suicide severity rating scale - lifetime recent:-:Pt:^Patient:-:C-SSRS


name: Columbia - suicide severity rating scale - lifetime recent


name: Non-specific active suicidal thoughts:Find:1Mo:^Patient:Ord


name: Active suicidal ideation with any methods (not plan) without intent to act:Find:1Mo:^Patient:Ord


name: Active suicidal ideation with any methods (not plan) without intent to act


name: Active suicidal ideation with some intent to act, without specific plan:Find:1Mo:^Patient:Ord


name: Active suicidal ideation with some intent to act, without specific plan


name: Active suicidal ideation with specific plan and intent:Find:1Mo:^Patient:Ord


name: Active suicidal ideation with specific plan and intent


name: Duration of most severe suicidal ideation:Find:Lifetime:^Patient:Ord:C-SSRS


name: Duration of most severe suicidal ideation


name: Duration of most severe suicidal ideation:Find:1Mo:^Patient:Ord:C-SSRS


name: Has subject engaged in non-suicidal self-injurious behavior:Find:Lifetime:^Patient:Ord


name: Has subject engaged in non-suicidal self-injurious behavior


name: Has subject engaged in non-suicidal self-injurious behavior:Find:3Mo:^Patient:Ord


name: Aborted or self-interrupted suicide attempt:Find:Lifetime:^Patient:Ord


name: Aborted or self-interrupted suicide attempts


name: Aborted or self-interrupted suicide attempts:Num:Lifetime:^Patient:Qn


name: Aborted or self-interrupted suicide attempt:Find:3Mo:^Patient:Ord


name: Aborted or self-interrupted suicide attempts:Num:3Mo:^Patient:Qn


name: Preparatory acts or suicidal behavior:Find:Lifetime:^Patient:Ord


name: Preparatory acts or suicidal behaviors:Num:Lifetime:^Patient:Qn


name: Preparatory acts or suicidal behavior:Find:3Mo:^Patient:Ord


name: Preparatory acts or suicidal behaviors:Num:3Mo:^Patient:Ord


name: Actual lethality or medical damage most lethal suicide attempt:Find:Lifetime:^Patient:Ord:C-SSRS


name: Actual lethality or medical damage most lethal suicide attempt


name: Potential lethality most lethal suicide attempt:Find:Lifetime:^Patient:Ord:C-SSRS


name: Potential lethality most lethal suicide attempt


name: Most severe suicidal ideation description:Find:1Mo:^Patient:Nom


name: Most severe suicidal ideation description


name: Most severe suicidal ideation description:Find:Lifetime:^Patient:Nom


name: Potential lethality initial or first suicide attempt:Find:Pt:^Patient:Ord:C-SSRS


name: Potential lethality initial or first suicide attempt


name: Potential lethality most recent suicide attempt:Find:Pt:^Patient:Ord:C-SSRS


name: Potential lethality most recent suicide attempt


name: Actual lethality or medical damage initial or first suicide attempt:Find:Pt:^Patient:Ord:C-SSRS


name: Actual lethality or medical damage initial or first suicide attempt


name: Actual lethality or medical damage most recent suicide attempt:Find:Pt:^Patient:Ord:C-SSRS


name: Actual lethality or medical damage most recent suicide attempt


name: Reasons for most severe suicidal ideation:Find:1Mo:^Patient:Ord:C-SSRS


name: Reasons for most severe suicidal ideation


name: Reasons for most severe suicidal ideation:Find:Lifetime:^Patient:Ord:C-SSRS


name: Deterrents of most severe suicidal ideation:Find:1Mo:^Patient:Ord:C-SSRS


name: Deterrents of most severe suicidal ideation


name: Deterrents of most severe suicidal ideation:Find:Lifetime:^Patient:Ord:C-SSRS


name: Controllability of most severe suicidal ideation:Find:1Mo:^Patient:Ord:C-SSRS


name: Controllability of most severe suicidal ideation


name: Controllability of most severe suicidal ideation:Find:Lifetime:^Patient:Ord:C-SSRS


name: Frequency of most severe suicidal ideation:Find:1Mo:^Patient:Ord:C-SSRS


name: Frequency of most severe suicidal ideation


name: Frequency of most severe suicidal ideation:Find:Lifetime:^Patient:Ord:C-SSRS


name: Most severe suicidal ideation:Type:1Mo:^Patient:Ord


name: Most severe suicidal ideation:Type:Lifetime:^Patient:Ord


name: Active suicidal ideation with specific plan and intent:Find:Lifetime:^Patient:Ord


name: Active suicidal ideation with some intent to act, without specific plan:Find:Lifetime:^Patient:Ord


name: Active suicidal ideation with any methods (not plan) without intent to act:Find:Lifetime:^Patient:Ord


name: Date of initial or first suicide attempt:Date:Pt:^Patient:Qn


name: Date of initial or first suicide attempt


name: Risk of adverse drug reaction sequence variation interpretation:Imp:Pt:Bld/Tiss:Nar


name: Risk of adverse drug reaction sequence variation interpretation


name: Hearing.ability to hear during 3D assessment period:Find:3D:^Patient:Ord:CMS Assessment


name: Hearing.ability to hear during 3D assessment period


name: Vision.ability to see in adequate light during 3D assessment period:Find:3D:^Patient:Ord:CMS Assessment


name: Vision.ability to see in adequate light during 3D assessment period


name: Platelet glycoprotein disorder:Imp:Pt:Bld:Nar:Flow cytometry


name: Platelet glycoprotein VI actual/normal:RelRto:Pt:Bld:Qn:Flow cytometry


name: Platelet CD49b actual/normal:RelRto:Pt:Bld:Qn:Flow cytometry


name: Platelet CD42b actual/normal:RelRto:Pt:Bld:Qn:Flow cytometry


name: Platelet CD42a actual/normal:RelRto:Pt:Bld:Qn:Flow cytometry


name: Platelet CD61 actual/normal:RelRto:Pt:Bld:Qn:Flow cytometry


name: Platelet CD41 actual/normal:RelRto:Pt:Bld:Qn:Flow cytometry


name: Platelet glycoprotein disorder panel:-:Pt:Bld:Qn:Flow cytometry


name: Thrombospondin type I domain-containing 7A Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IF


name: Power level^peak during exercise:EngRat:Pt:^Patient:Qn


name: Treatment to which interaction between genetic variants confers synergy:Prid:Pt:Bld/Tiss:Nom


name: Treatment to which genetic variant confers resistance:Prid:Pt:Bld/Tiss:Nom


name: Genetic variant effect on drug resistance:Find:Pt:Bld/Tiss:Nar


name: Genetic variant effect on drug sensitivity:Find:Pt:Bld/Tiss:Nar


name: Available treatment related to genetic variant and not to patient diagnosis:Prid:Pt:Bld/Tiss:Nom


name: Available treatment related to genetic variant and to patient diagnosis:Prid:Pt:Bld/Tiss:Nom


name: Treatment to which interaction between genetic variants confers resistance:Prid:Pt:Bld/Tiss:Nom


name: Neutrophil CD64 & Monocyte HLA DR panel:-:Pt:Bld:Qn:Flow cytometry


name: Monotypic plasma cell identification & risk stratification panel:-:Pt:Bone mar:-:Molgen


name: Monotypic plasma cell identification & risk stratification panel


name: Plasma cells.polyclonal/Cells counted:NFr:Pt:Bone mar:Qn:Flow cytometry


name: Monotypic plasma cell DNA ploidy:Type:Pt:Bone mar:Nom:Flow cytometry


name: Monotypic plasma cell DNA index:Ratio:Pt:Bone mar:Qn:Flow cytometry


name: Plasma cells.monotypic.S phase/100 cells:NFr:Pt:Bone mar:Qn:Flow cytometry


name: Plasma cells.monotypic.S phase/100 cells


name: Plasma cells.monotypic population:Prid:Pt:Bone mar:Nom:Flow cytometry


name: Plasma cell DNA content & proliferation panel:-:Pt:Bone mar:-:Flow cytometry


name: Plasma cell DNA content & proliferation panel


name: Genetic variant diagnostic significance:Imp:Pt:Bld/Tiss:Nar


name: Genetic variant prognostic significance:Imp:Pt:Bld/Tiss:Nar


name: Gene studied with no variant found:Prid:Pt:Bld/Tiss:Nom


name: Variant of unknown significance:Prid:Pt:Bld/Tiss:Nom


name: Summary of interaction between genetic variants:Imp:Pt:Bld/Tiss:Nar


name: Krebs von den Lungen-6:ACnc:Pt:Ser/Plas:Qn:IA


name: Anaplasma phagocytophilum & Ehrlichia chaffeensis Ab.IgG & IgM panel:-:Pt:Ser:-


name: Anaplasma phagocytophilum & Ehrlichia chaffeensis Ab.IgG & IgM panel


name: von Willebrand factor cleaving protease activity:CCnc:Pt:PPP:Qn:Chromo


name: Indexing - national clinical trial number:-:-:^FDA product label:Nar


name: Indexing - national clinical trial number


name: Columbia - suicide severity rating scale screener - recent:-:Pt:^Patient:-:C-SSRS


name: Columbia - suicide severity rating scale screener - recent


name: Serratia sp DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Salmonella sp DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Pseudomonas aeruginosa DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Proteus mirabilis DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Neisseria meningitidis DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Gram positive bacteria DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Bacterial carbapenem resistance blaOXA-23-like+blaOXA-48-like genes:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Stenotrophomonas maltophilia DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Serratia marcescens DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Proteus sp DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Morganella morganii DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Klebsiella pneumoniae DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Fusobacterium nucleatum DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Haemophilus influenzae DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Klebsiella oxytoca DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Fusobacterium necrophorum DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Enterobacter aerogenes+Enterobacter amnigenus+Enterobacter gergoviae DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Escherichia coli DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Cronobacter sakazakii DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Citrobacter sp DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Enterobacter cloacae complex DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Bacteroides fragilis DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Acinetobacter baumannii DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Gram negative blood culture panel:-:Pt:Bld.pos growth:-:Probe.amp.tar


name: Platelet aggregation.epinephrine induced^10 umol/L:RelACnc:Pt:PRP:Qn


name: Platelet aggregation.epinephrine induced^5 umol/L:RelACnc:Pt:PRP:Qn


name: Platelet aggregation.ristocetin induced^5 ug/mL:RelACnc:Pt:PRP:Qn


name: COMT gene product metabolic activity interpretation:Imp:Pt:Bld/Tiss:Ord:Molgen


name: COMT gene product metabolic activity interpretation


name: SLCO1B1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Mechanical circulatory support+consultation note:Find:Pt:{Setting}:Doc:{Role}


name: Mechanical circulatory support+consultation note


name: Deprecated Disorganized thinking in last 3 days [CMS Assessment]


name: Deprecated Inattention in last 3 days [CMS Assessment]


name: IRF-PAI v4.0, LCDS v5.00 - Signs and Symptoms of Delirium (from CAM):-:3D:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Signs and Symptoms of Delirium (from CAM)


name: Alpha 1 antitrypsin fecal clearance panel:-:Pt:Ser/Plas+Stool:Qn


name: Alpha 1 antitrypsin fecal clearance panel


name: APOA1 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Glial fibrillary acidic protein.alpha subunit Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: Glial fibrillary acidic protein.alpha subunit Ab.IgG:PrThr:Pt:CSF:Ord:CBA IFA


name: Glial fibrillary acidic protein.alpha subunit Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Glial fibrillary acidic protein.alpha subunit Ab.IgG:PrThr:Pt:Ser:Ord:CBA IFA


name: Gamma aminobutyrate B receptor Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: Gamma aminobutyrate B receptor Ab.IgG:PrThr:Pt:CSF:Ord:CBA IFA


name: Gamma aminobutyrate B receptor Ab.IgG:Titr:Pt:Ser/Plas:SemiQn:IF


name: Gamma aminobutyrate B receptor Ab.IgG:PrThr:Pt:Ser/Plas:Ord:CBA IFA


name: Busulfan^4H post busulfan infusion completion:MCnc:Pt:Plas:Qn


name: Busulfan^2H post busulfan infusion completion:MCnc:Pt:Plas:Qn


name: Busulfan^1H post busulfan infusion completion:MCnc:Pt:Plas:Qn


name: Busulfan^immediately post busulfan infusion completion:MCnc:Pt:Plas:Qn


name: Herpes Simplex Virus 2 DNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Herpes Simplex Virus 1 DNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Herpes Simplex Virus 1 & 2 DNA Panel:-:Pt:Bld:-:Non-probe.amp.tar


name: Coagulation factor VIII Inhibitor:ACnc:Pt:PPP:Qn:Chromo


name: Busulfan area under the curve panel:-:Stdy:Plas:Qn


name: Cortisol post corticotropin releasing hormone stimulation panel:-:Pt:Ser/Plas:Qn


name: Cortisol post corticotropin releasing hormone stimulation panel


name: Cortisol^10M post 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^1M pre 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^2M post 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^5M pre 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Columbia - suicide severity rating scale - very young child or cognitively impaired - lifetime recent:-:Pt:^Patient:-:C-SSRS


name: Columbia - suicide severity rating scale - very young child or cognitively impaired - lifetime recent


name: Has subject engaged in self-injurious behavior, intent unknown:Find:3Mo:^Patient:Ord


name: Has subject engaged in self-injurious behavior, intent unknown


name: Has subject engaged in self-injurious behavior, intent unknown:Find:Lifetime:^Patient:Ord


name: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG:PrThr:Pt:Ser/Plas:Ord:CBA IFA


name: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG:Titr:Pt:Ser/Plas:SemiQn:IF


name: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG:PrThr:Pt:CSF:Ord:CBA IFA


name: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Moxifloxacin 3.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Metabotropic glutamate receptor 1 Ab.IgG:PrThr:Pt:Ser:Ord:CBA IFA


name: Metabotropic glutamate receptor 1 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Metabotropic glutamate receptor 1 Ab.IgG:PrThr:Pt:CSF:Ord:CBA IFA


name: Metabotropic glutamate receptor 1 Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: N-methyl-D-aspartate receptor subunit 1 Ab.IgG:PrThr:Pt:CSF:Ord:CBA IFA


name: N-methyl-D-aspartate receptor subunit 1 Ab.IgG:PrThr:Pt:Ser:Ord:CBA IFA


name: Rickettsia rickettsii & Coxiella burnetii phase 1 & Coxiella burnetii phase 2 Ab.IgG panel:-:Pt:Ser:-


name: Rickettsia rickettsii & Coxiella burnetii phase 1 & Coxiella burnetii phase 2 Ab.IgG panel


name: Frequency of most severe suicidal ideation:Find:1Mo:^Patient:Ord:C-SSRS.PCI


name: Frequency of most severe suicidal ideation:Find:Lifetime:^Patient:Ord:C-SSRS.PCI


name: Multisection^WO & W contrast IV:Find:Pt:Head & Neck>Spine.cervical:Doc:CT


name: Multisection:Find:Pt:Lower extremity.bilateral>Lower extremity arteries+Lower extremity veins:Doc:US.doppler


name: Views 2 or 3:Find:Pt:Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx:Doc:XR


name: Views 4 or 5:Find:Pt:Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx:Doc:XR


name: Views GE 6:Find:Pt:Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx:Doc:XR


name: Atrial contraction strain rate.max:ARat:Pt:Heart.ventricle.left:Qn:US.3D


name: Atrial contraction strain rate.circumferential.max:LenRto:Pt:Heart.ventricle.left:Qn:US.3D


name: Atrial contraction strain rate.circumferential.max


name: Atrial contraction strain rate.longitudinal.max:ARat:Pt:Heart.ventricle.left:Qn:US.3D


name: Atrial contraction strain rate.longitudinal.max


name: Circumferential strain rate.early diastole.max:ARat:Pt:Heart.ventricle.left:Qn:US.3D


name: Longitudinal strain rate.early diastole.max:ARat:Pt:Heart.ventricle.left:Qn:US.3D


name: Regurgitant volume:Vol:Pt:Tricuspid valve:Qn:US.doppler+Calculated by PISA method


name: Blood flow reversal.systolic:Find:Pt:Hepatic vein:Ord:US.doppler


name: Regurgitant blood velocity-time integral:Len:Pt:Tricuspid valve:Qn:US.doppler


name: Regurgitant blood velocity-time integral


name: Regurgitant orifice area:Area:Pt:Tricuspid valve:Qn:US.doppler.color


name: Blood flow reversal.diastolic:Find:Pt:Pulmonary artery.main:Ord:US.doppler


name: Pressure gradient.early diastole.max:PressDiff:Pt:Pulmonic valve:Qn:US.doppler


name: Regurgitant blood flow velocity.early diastole:Vel:Pt:Pulmonary valve:Qn:US.doppler.PW


name: Regurgitant blood flow velocity.early diastole


name: Blood flow velocity.S2 wave:Vel:Pt:Pulmonary vein:Qn:US.doppler.PW


name: Blood flow velocity.S1 wave:Vel:Pt:Pulmonary vein:Qn:US.doppler.PW


name: Regurgitant blood velocity-time integral:Len:Pt:Mitral valve:Qn:US.doppler


name: Regurgitant fraction:VFr:Pt:Aortic valve:Qn:US.doppler+Calculated by PISA method


name: Regurgitant blood velocity-time integral:Len:Pt:Aortic valve:Qn:US.doppler


name: Velocity-time integral.left ventricular outflow tract/velocity-time integral.aortic valve:LenRto:Pt:Heart:Qn:US.doppler


name: Velocity-time integral.left ventricular outflow tract/velocity-time integral.aortic valve


name: Blood flow velocity.max.left ventricular outflow tract/blood flow.max.aortic valve:VelRto:Pt:Heart:Qn:US.doppler


name: Blood flow velocity.max.left ventricular outflow tract/blood flow.max.aortic valve


name: End-systolic volume/Body surface area:ArVol:Pt:Heart.atrium.left:Qn:US.2D.A2C+Calc by single plane area-length method


name: End-systolic volume/Body surface area:ArVol:Pt:Heart.atrium.left:Qn:US.2D.A4C+Calc by single plane area-length method


name: End-systolic volume/Body surface area:ArVol:Pt:Heart.atrium.left:Qn:US.2D.A2C+Calc by single plane method of disks


name: End-systolic volume/Body surface area:ArVol:Pt:Heart.atrium.left:Qn:US.2D.A4C+Calc by single plane method of disks


name: End-systolic volume:Vol:Pt:Heart.atrium.left:Qn:US.2D.A2C+Calc by single plane area-length method


name: End-systolic volume:Vol:Pt:Heart.atrium.left:Qn:US.2D.A4C+Calc by single plane area-length method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calc by single plane area-length method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calc by single plane area-length method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by biplane area-length method


name: Cardiac output:VRat:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calc by single plane area-length method


name: Cardiac output:VRat:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calc by single plane area-length method


name: Cardiac output:VRat:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by biplane area-length method


name: Cardiac output:VRat:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calc by single plane method of disks


name: Cardiac output:VRat:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calc by single plane method of disks


name: Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calc by single plane area-length method


name: Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calc by single plane area-length method


name: Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by biplane area-length method


name: Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calc by single plane method of disks


name: Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calc by single plane method of disks


name: End-systolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calc by single plane area-length method


name: End-systolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calc by single plane area-length method


name: End-systolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by biplane area-length method


name: End-diastolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calc by single plane area-length method


name: End-diastolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calc by single plane area-length method


name: End-diastolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by biplane area-length method


name: Regurgitant blood flow pressure half-time:Time:Pt:Pulmonary valve:Qn:US.doppler


name: Did you or others you live with eat smaller meals or skip meals because you didn't have money for food in the past 2M:Find:2M:^Patient:Ord:WellRx


name: Did you or others you live with eat smaller meals or skip meals because you didn't have money for food in the past 2M


name: Are you homeless or worried that you might be in the future:Find:Pt:^Patient:Ord:WellRx


name: Are you homeless or worried that you might be in the future


name: Do you have trouble paying for your gas or electricity bills:Find:Pt:^Patient:Ord:WellRx


name: Do you have trouble paying for your gas or electricity bills


name: Do you have trouble finding or paying for transportation:Find:Pt:^Patient:Ord:WellRx


name: Do you have trouble finding or paying for transportation


name: Do you need daycare, or better daycare, for your kids:Find:Pt:^Patient:Ord:WellRx


name: Do you need daycare, or better daycare, for your kids


name: Are you unemployed or without regular income:Find:Pt:^Patient:Ord:WellRx


name: Are you unemployed or without regular income


name: Do you need help finding a better job:Find:Pt:^Patient:Ord:WellRx


name: Do you need help getting more education:Find:Pt:^Patient:Ord:WellRx


name: Are you concerned about someone in your home using drugs or alcohol:Find:Pt:^Patient:Ord:WellRx


name: Are you concerned about someone in your home using drugs or alcohol


name: Do you need help with legal issues:Find:Pt:^Patient:Ord:WellRx


name: Have you been at the emergency department more than twice in the last 6Mo:Find:6Mo:^Patient:Ord:WellRx


name: Have you been at the emergency department more than twice in the last 6Mo


name: Emergency department visits in last 6Mo:Num:6Mo:^Patient:Qn


name: Hospitalized in the last 6Mo:Find:6Mo:^Patient:Ord


name: Number of times hospitalized in last 6Mo:Num:6Mo:^Patient:Qn


name: Number of times hospitalized in last 6 months


name: Do you feel unsafe in your daily life:Find:Pt:^Patient:Ord:WellRx


name: Is anyone in your home threatening or abusing you:Find:Pt:^Patient:Ord:WellRx


name: Is anyone in your home threatening or abusing you


name: Gas & CO & electrolytes panel:-:Pt:BldA:Qn


name: Thrombospondin type I domain-containing 7A Ab.IgG:Titr:Pt:Ser/Plas:SemiQn:CBA IFA


name: Nonalcoholic steatohepatitis & fibrosis panel:-:Pt:Ser/Plas:-


name: Nonalcoholic steatohepatitis & fibrosis panel


name: Gram negative bacterial resistance panel:-:Pt:Isolate/Specimen:-:Molgen


name: Gram negative bacterial resistance panel


name: Bacterial beta-lactam resistance AmpC blaCMY-2 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial beta-lactam resistance AmpC blaDHA gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial colistin resistance mcr-2 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Platelet aggregation.ristocetin induced^15 ug/mL:RelACnc:Pt:PRP:Qn


name: Palmitoyl protein thioesterase 1 & Tripeptidyl peptidase 1 panel:-:Pt:Fibroblasts:-


name: Palmitoyl protein thioesterase 1 & Tripeptidyl peptidase 1 panel


name: Palmitoyl protein thioesterase 1 & Tripeptidyl peptidase 1 panel:-:Pt:WBC:-


name: Ethyl sulfate & Ethyl glucuronide panel:-:Pt:Urine:-


name: Epstein Barr virus Ab panel:-:Pt:Ser^Donor:-


name: Epstein Barr virus nuclear Ab:PrThr:Pt:Ser^Donor:Ord:IA


name: Epstein Barr virus capsid Ab.IgG:PrThr:Pt:Ser^Donor:Ord:IA


name: Epstein Barr virus capsid Ab.IgM:PrThr:Pt:Ser^Donor:Ord:IA


name: Francisella tularensis Ab.IgG & IgM panel:-:Pt:Ser:-


name: Francisella tularensis Ab.IgG & IgM panel


name: Francisella tularensis Ab.IgG & IgM:Imp:Pt:Ser:Nom


name: Indexing - drug interactions:-:-:^FDA product label:Nar


name: Brassica oleracea var gongylodes Ab.IgE:ACnc:Pt:Ser:Qn


name: Brassica oleracea var botrytis cooked Ab.IgE:ACnc:Pt:Ser:Qn


name: Brassica oleracea var capitata f rubra Ab.IgE:ACnc:Pt:Ser:Qn


name: HTLV I & II Ab band pattern:Imp:Pt:CSF:Nom:Line blot


name: HTLV I & II Ab.IgG band:Type:Pt:CSF:Nom:Line blot


name: HTLV I+II Ab.IgG:PrThr:Pt:CSF:Ord:Line blot


name: Parainfluenza virus 1+2+3+4 Ab.IgG:PrThr:Pt:Ser:Ord:IA


name: Mumps virus N gene:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Mumps virus RNA & N gene panel:-:Pt:XXX:-


name: Atypical porcine pestivirus RNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Atypical porcine pestivirus RNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Porcine circovirus type 3 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Mycoplasma hyorhinis Ab.IgG/Positive control:RelRto:Pt:Ser:Qn:IA


name: Mycoplasma hyorhinis Ab.IgG/Positive control


name: Salmonella choleraesuis+infantis+typhimurium Ab/Positive control:RelRto:Pt:XXX:Qn:IA


name: Salmonella choleraesuis+infantis+typhimurium Ab/Positive control


name: Influenza virus A PB2 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Influenza virus A PB1 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Influenza virus A PA gene:Seq:Pt:Isolate:Nom:Sequencing


name: Influenza virus A NP gene:Seq:Pt:Isolate:Nom:Sequencing


name: Influenza virus A NS1 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Porcine astrovirus type 3 RNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Human papilloma virus 16+18 E6+E7 mRNA:PrThr:Pt:Tiss:Ord:Probe


name: Human papilloma virus 6+11 E6+E7 mRNA:PrThr:Pt:Tiss:Ord:Probe


name: Large B-cell lymphoma and cell of origin:Type:Pt:Tiss:Nom


name: Primary mediastinal large B-cell lymphoma:Likelihood:Pt:Tiss:Qn


name: Diffuse large B-cell lymphoma.activated B-cell subtype:Likelihood:Pt:Tiss:Qn


name: Diffuse large B-cell lymphoma cell of origin:Type:Pt:Tiss:Nom


name: Diffuse large B-Cell lymphoma cell of origin subclassification panel:-:Pt:Tiss:-


name: Diffuse large B-Cell lymphoma cell of origin subclassification panel


name: Large B-cell lymphoma classification panel:-:Pt:Tiss:-


name: Large B-cell lymphoma classification panel


name: Varicella zoster virus Ab.IgM+total:PrThr:Pt:CSF:Ord


name: Lymphocytic choriomeningitis virus Ab.IgG+IgM:PrThr:Pt:CSF:Ord


name: F5 gene HR2 haplotype:Geno:Pt:Bld:Nom:Molgen


name: Time to microorganism growth detection:Time:*:Specimen:Qn


name: Glucose tolerance & insulin sensitivity 2H panel:-:-:Ser/Plas:-


name: Glucose tolerance & insulin sensitivity 2H panel


name: MYCN gene copy number/Chromosome 2 copy number:NRto:Pt:Tiss:Qn:FISH


name: MYCN gene copy number/Chromosome 2 copy number


name: MYCN gene copy number/nucleus:EntNum:Pt:Tiss:Qn:FISH


name: Chromosome 2 copy number/nucleus:EntNum:Pt:Tiss:Qn:FISH


name: 1p chromosome deletion/1q chromosome deletion:NRto:Pt:Tiss:Qn:FISH


name: 19q chromosome deletion/19p chromosome deletion:NRto:Pt:Tiss:Qn:FISH


name: Chromosome 12 copy number/nucleus:EntNum:Pt:Tiss:Qn:FISH


name: MDM2 gene copy number/nucleus:EntNum:Pt:Tiss:Qn:FISH


name: MDM2 gene copy number/Chromosome 12 copy number:NRto:Pt:Tiss:Qn:FISH


name: MDM2 gene copy number/Chromosome 12 copy number


name: F9 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: NTRK1 gene & NTRK2 gene & NTRK3 gene rearrangements:Find:Pt:Tiss:Doc:Molgen


name: SERPINC1 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: PROC gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Calories burned^during weight training:EngRat:XXX:^Patient:Qn


name: Calories burned^during aerobic activity:EngRat:XXX:^Patient:Qn


name: Calories burned^while playing a sport:EngRat:XXX:^Patient:Qn


name: Epstein Barr virus DNA:ACnc:Pt:Bld:Qn:Probe.amp.tar


name: Epstein Barr virus DNA:LaCnc:Pt:Bld:Qn:Probe.amp.tar


name: HOGA1 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Primary hyperoxaluria multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Primary hyperoxaluria multigene analysis


name: UGT1A1 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Toxoplasma gondii Ab.IgG panel:-:Pt:Ser^Donor:-


name: Gamma aminobutyrate B receptor Ab:PrThr:Pt:Ser:Ord:CBA IFA


name: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab:PrThr:Pt:Ser:Ord:CBA IFA


name: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab:PrThr:Pt:Ser:Ord:CBA IFA


name: N-methyl-D-aspartate receptor subunit 1 Ab:PrThr:Pt:Ser:Ord:CBA IFA


name: Methane/Expired gas^2H post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Methane/Expired gas^1.5H post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Methane/Expired gas^1H post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Methane/Expired gas^45M post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Methane/Expired gas^30M post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Methane/Expired gas^15M post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Methane/Expired gas^pre dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Methane/Expired gas^post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Progress note:Find:Pt:{Setting}:Doc:Maternal and fetal medicine


name: Plan of care note:Find:Pt:{Setting}:Doc:Healthcare navigator


name: Discharge summary note:Find:Pt:{Setting}:Doc:Healthcare navigator


name: ABO & Rh group^during infancy:Type:Pt:Bld:Nom


name: A little u super little b Ag:PrThr:Pt:RBC:Ord


name: K Ag^post transfusion reaction:PrThr:Pt:RBC:Ord


name: Rh antigens & K Ag post transfusion reaction panel:-:Pt:Bld:-


name: Rh antigens & K Ag post transfusion reaction panel


name: ABO & Rh group post transfusion reaction panel:-:Pt:Bld:-


name: ABO & Rh group post transfusion reaction panel


name: K Ag^post hematopoietic stem cell transplant:PrThr:Pt:RBC:Ord


name: Rh antigens & K Ag post hematopoietic stem cell transplant panel:-:Pt:Bld:-


name: Rh antigens & K Ag post hematopoietic stem cell transplant panel


name: D Ag^post hematopoietic stem cell transplant:PrThr:Pt:RBC:Ord


name: ABO group^post hematopoietic stem cell transplant:Type:Pt:Bld:Nom


name: ABO & Rh group^post hematopoietic stem cell transplant:Type:Pt:Bld:Nom


name: ABO & Rh group post hematopoietic stem cell transplant panel:-:Pt:Bld:-


name: ABO & Rh group post hematopoietic stem cell transplant panel


name: Rh antigens & K Ag during infancy panel:-:Pt:Bld:-


name: ABO & Rh group during infancy panel:-:Pt:Bld:-


name: Metamyelocytes.neutrophilic/100 leukocytes:NFr:Pt:Bone mar:Qn:Manual count


name: Note:Find:Pt:Outpatient:Doc:Wound, ostomy, and continence care


name: Consultation note:Find:Pt:{Setting}:Doc:Wound, ostomy, and continence care


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Developmental-behavioral pediatrics


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Eating disorders


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Heart failure+Transplant cardiology


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Integrative medicine


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Physical medicine and rehab


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Plastic surgery


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Wound, ostomy, and continence care


name: Chikungunya virus Ab.IgM & IgG panel:-:Pt:Ser/Plas:-


name: Hydrogen/Expired gas^2H post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^1.5H post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^1H post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^45M post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^30M post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^15M post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^pre dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Carbohydrate challenge panel:-:Pt:Exhl gas:-


name: Sodium^1H post dose vasopressin:SCnc:Pt:Ser/Plas:Qn


name: Potassium^1H post dose vasopressin:SCnc:Pt:Ser/Plas:Qn


name: Creatinine^1H post dose vasopressin:MCnc:Pt:Ser/Plas:Qn


name: Chloride^1H post dose vasopressin:SCnc:Pt:Ser/Plas:Qn


name: Bicarbonate^1H post dose vasopressin:SCnc:Pt:Ser/Plas:Qn


name: Anion Gap 3^1H post dose vasopressin:SCnc:Pt:Ser/Plas:Qn


name: Urea nitrogen^1H post dose vasopressin:MCnc:Pt:Ser/Plas:Qn


name: Osmolality^1H post dose vasopressin:Osmol:Pt:Ser/Plas:Qn


name: Osmolality^1H post dose vasopressin:Osmol:Pt:Urine:Qn


name: Sodium^2H post dose vasopressin:SCnc:Pt:Ser/Plas:Qn


name: Potassium^2H post dose vasopressin:SCnc:Pt:Ser/Plas:Qn


name: Creatinine^2H post dose vasopressin:MCnc:Pt:Ser/Plas:Qn


name: Chloride^2H post dose vasopressin:SCnc:Pt:Ser/Plas:Qn


name: Bicarbonate^2H post dose vasopressin:SCnc:Pt:Ser/Plas:Qn


name: Anion Gap 3^2H post dose vasopressin:SCnc:Pt:Ser/Plas:Qn


name: Urea nitrogen^2H post dose vasopressin:MCnc:Pt:Ser/Plas:Qn


name: Osmolality^2H post dose vasopressin:Osmol:Pt:Ser/Plas:Qn


name: Osmolality^2H post dose vasopressin:Osmol:Pt:Urine:Qn


name: Adenovirus A+B+C+D+E DNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: My practice makes it easy for me to get care:Find:Pt:^Patient:Ord:PCPCM


name: My practice makes it easy for me to get care


name: My practice is able to provide most of my care:Find:Pt:^Patient:Ord:PCPCM


name: My practice is able to provide most of my care


name: In caring for me, my doctor considers all the factors that affect my health:Find:Pt:^Patient:Ord:PCPCM


name: In caring for me, my doctor considers all the factors that affect my health


name: My practice coordinates the care I get from multiple places:Find:Pt:^Patient:Ord:PCPCM


name: My practice coordinates the care I get from multiple places


name: My doctor or practice knows me as a person:Find:Pt:^Patient:Ord:PCPCM


name: My doctor or practice knows me as a person


name: My doctor and I have been through a lot together:Find:Pt:^Patient:Ord:PCPCM


name: My doctor and I have been through a lot together


name: My doctor or practice stands up for me:Find:Pt:^Patient:Ord:PCPCM


name: The care I get takes into account knowledge of my family:Find:Pt:^Patient:Ord:PCPCM


name: The care I get takes into account knowledge of my family


name: The care I get in this practice is informed by knowledge of my community:Find:Pt:^Patient:Ord:PCPCM


name: The care I get in this practice is informed by knowledge of my community


name: Over time, my practice helps me to stay healthy:Find:Pt:^Patient:Ord:PCPCM


name: Over time, my practice helps me to stay healthy


name: Over time, my practice helps me to meet my goals:Find:Pt:^Patient:Ord:PCPCM


name: Over time, my practice helps me to meet my goals


name: Mycobacterium tuberculosis complex resistance panel:-:Pt:Isolate/Specimen:-:Molgen


name: Mycobacterium tuberculosis complex resistance panel


name: Bacterial katG gene drug resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Bacterial inhA gene drug resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Bacterial fabG1 gene drug resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Bacterial ahpC gene drug resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Bacterial embB gene drug resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Bacterial pncA gene drug resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Bacterial gyrA gene drug resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Bacterial gidB gene drug resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Bacterial rrs gene drug resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Bacterial rpsL gene drug resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Bacterial eis gene drug resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Bacterial rpoB gene drug resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Person-Centered Primary Care Measure:-:Pt:^Patient:-:PCPCM


name: Color Me Healthy - children's symptom assessment app panel:-:Pt:^Patient:-


name: Color Me Healthy - children's symptom assessment app panel


name: PDX1 gene full mutation analysis:Prid:Pt:Bld/Tiss:Nom:Sequencing


name: TYMP gene full mutation analysis:Prid:Pt:Bld/Tiss:Nom:Sequencing


name: RRM2B gene full mutation analysis:Prid:Pt:Bld/Tiss:Nom:Sequencing


name: Multisection^WO & W contrast:Find:Pt:Chest>Spine.thoracic & Abdomen>Spine.lumbar:Doc:MR


name: Multisection^WO & W contrast IV && Multisection^W contrast IV:Find:Pt:Chest:Doc:MR && MR.angio


name: Views for dialysis fistula^W contrast IA & Guidance for percutaneous transluminal angioplasty + transcatheter placement of stent:Find:Pt:XXX>Vessels:Doc:RF.angio


name: Views for dialysis fistula^W contrast IA & Guidance for percutaneous transluminal angioplasty:Find:Pt:XXX>Vessels:Doc:RF.angio


name: Views for dialysis fistula^W contrast IA:Find:Pt:XXX>Vessels:Doc:RF.angio


name: Views limited for therapy or embolization or infusion^W contrast via existing catheter:Find:Pt:XXX:Doc:RF.angio


name: Views limited for therapy or embolization or infusion


name: Views^W contrast IV:Find:Pt:Extremity.unilateral>Extremity vessels:Doc:RF.angio


name: Collagen type VII Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IA


name: Cytosolic 5'-nucleotidase 1A Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IA


name: Dense fine speckled 70 protein Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IA


name: Hantavirus seoul Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus seoul Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Epstein Barr virus early diffuse Ab.IgA:ACnc:Pt:Ser/Plas:Qn:IA


name: Volume.expired per minute/Carbon dioxide production^W exercise:VRto:Pt:^Patient:Qn


name: Volume.expired per minute/Carbon dioxide production


name: Oxygen consumption/Heart rate^peak during exercise:VRat:Pt:^Patient:Qn


name: Oxygen consumption/Body weight^peak during exercise:VRatCnt:Pt:^Patient:Qn


name: Intravascular end diastolic:Pres:Pt:Pulmonary artery:Qn:Cardiac catheterization


name: Ventilatory equivalent for carbon dioxide^W exercise:VRto:Pt:^Patient:Qn


name: Ventilatory equivalent for carbon dioxide


name: Vasopressin challenge post water deprivation panel:-:Pt:Urine+Ser/Plas:-


name: Vasopressin challenge post water deprivation panel


name: Water deprivation challenge panel:-:Pt:Urine+Ser/Plas:-


name: Funeral service licensee or other agent assuming custody of the body of the deceased:Pn:Pt:Personnel:Nom


name: Funeral service licensee or other agent assuming custody of the body of the deceased


name: Funeral service licensee identifier:ID:Pt:Facility:Nom


name: 1 hour post busulfan infusion completion


name: 4 hours post busulfan infusion completion


name: immediately after 1:1 addition of normal plasma and heparin neutralization


name: immediately post busulfan infusion completion


name: Blood flow velocity.max.left ventricular outflow tract


name: Busulfan^1H post busulfan infusion completion


name: Busulfan^2H post busulfan infusion completion


name: Busulfan^4H post busulfan infusion completion


name: Busulfan^immediately post busulfan infusion completion


name: Coagulation dilute Russell viper venom induced.excess phospholipid actual/normal^post heparin neutralization


name: Coagulation dilute Russell viper venom induced.excess phospholipid^post heparin neutralization


name: Coagulation dilute Russell viper venom induced.factor substitution^immediately after 1:1 addition of normal plasma+heparin neutralization


name: Coagulation dilute Russell viper venom induced^post heparin neutralization


name: Coagulation surface induced.lupus sensitive.excess phospholipid actual/Normal^post heparin neutralization


name: Coagulation surface induced.lupus sensitive.excess phospholipid^post heparin neutralization


name: Coagulation surface induced.lupus sensitive^post heparin neutralization


name: Coagulation surface induced^post heparin neutralization


name: Coagulation tissue factor induced.INR^post heparin neutralization


name: Coagulation tissue factor induced^post heparin neutralization


name: Compensation and pension examination note


name: CYP3A4 gene product metabolic activity interpretation


name: Evaluation and management of a specific problem


name: Fistula^W contrast IA & Guidance for percutaneous transluminal angioplasty + transcatheter placement of stent


name: Hydrogen/Expired gas^1.5H post dose carbohydrate


name: Hydrogen/Expired gas^15M post dose carbohydrate


name: Hydrogen/Expired gas^1H post dose carbohydrate


name: Hydrogen/Expired gas^2H post dose carbohydrate


name: Hydrogen/Expired gas^30M post dose carbohydrate


name: Hydrogen/Expired gas^45M post dose carbohydrate


name: Hydrogen/Expired gas^post dose carbohydrate


name: Hydrogen/Expired gas^pre dose carbohydrate


name: Methane/Expired gas^1.5H post dose carbohydrate


name: Methane/Expired gas^15M post dose carbohydrate


name: Methane/Expired gas^1H post dose carbohydrate


name: Methane/Expired gas^2H post dose carbohydrate


name: Methane/Expired gas^30M post dose carbohydrate


name: Methane/Expired gas^45M post dose carbohydrate


name: Methane/Expired gas^post dose carbohydrate


name: Methane/Expired gas^pre dose carbohydrate


name: Multisection^WO & W contrast IV && multisection


name: Oxygen consumption/Body weight^peak during exercise


name: Oxygen consumption/Heart rate^peak during exercise


name: Platelet aggregation.epinephrine induced^10 umol/L


name: Platelet aggregation.epinephrine induced^5 umol/L


name: Platelet aggregation.ristocetin induced^15 ug/mL


name: Platelet aggregation.ristocetin induced^5 ug/mL


name: Protein catabolic rate^^adjusted for body weight


name: Sit to stand with use of upper extremities


name: Ventilatory equivalent for carbon dioxide^W exercise


name: Views for dialysis fistula^W contrast IA


name: Views for dialysis fistula^W contrast IA & Guidance for percutaneous transluminal angioplasty


name: Views for dialysis fistula^W contrast IA & Guidance for percutaneous transluminal angioplasty + transcatheter placement of stent


name: Views limited for therapy or embolization or infusion^W contrast via existing catheter


name: Volume.expired per minute/Carbon dioxide production^W exercise


name: Confusion Assessment Method for CMS Assessment


name: Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be (NuMoM2b)


name: Revised Prenatal Distress Questionnaire (NuPDQ)


name: US.2D.A2C+Calc by single plane area-length method


name: US.2D.A4C+Calc by single plane area-length method


name: 7-Alpha,12-alpha dihydroxycholest-4-en-3-one and 7-Alpha hydroxy-4-cholesten-3-one panel | Blood | Chemistry Panels


name: 7-Alpha,12-alpha dihydroxycholest-4-en-3-one and 7-Alpha hydroxy-4-cholesten-3-one panel | DBS | Chemistry Panels


name: 7-Alpha,12-alpha dihydroxycholest-4-en-3-one and 7-Alpha hydroxy-4-cholesten-3-one panel | Serum or Plasma | Chemistry Panels


name: ABO and Rh group during infancy panel | Blood | Blood Bank Panels


name: ABO and Rh group panel | Blood cord | Blood Bank Panels


name: ABO and Rh group panel | Blood product unit | Blood | Blood Bank Panels


name: ABO and Rh group post hematopoietic stem cell transplant panel | Blood | Blood Bank Panels


name: ABO and Rh group post transfusion reaction panel | Blood | Blood Bank Panels


name: Abortion consent | {Setting} | Document ontology


name: ACAT1 gene full mutation analysis | Blood or Tissue | Mutations


name: Adenovirus and Bocavirus DNA panel | Lower respiratory specimen | Microbiology Panels


name: Adenovirus and Bocavirus DNA panel | Upper respiratory specimen | Microbiology Panels


name: ADHD action plan | {Setting} | Document ontology


name: Administrative note | {Setting} | Document ontology


name: Administrative note | Custodial care facility | Document ontology


name: Administrative note | Patient's home | Document ontology


name: Admission evaluation note | {Setting} | Document ontology


name: Admission evaluation note | Custodial care facility | Document ontology


name: Admission evaluation note | Emergency department | Document ontology


name: Admission evaluation note | Hospital | Document ontology


name: Admission evaluation note | Intensive care unit | Document ontology


name: Admission evaluation note | Long term care facility | Document ontology


name: Admission evaluation note | Observation unit | Document ontology


name: Admission evaluation note | Patient's home | Document ontology


name: Admission history and physical note | {Setting} | Document ontology


name: Admission history and physical note | Emergency department | Document ontology


name: Admission history and physical note | Hospital | Document ontology


name: Admission notification note | {Setting} | Document ontology


name: Admission notification note | Hospital | Document ontology


name: Advance directives | {Setting} | Document ontology


name: Adverse event note | {Setting} | Document ontology


name: Against medical advice note | {Setting} | Document ontology


name: Agreement | {Setting} | Document ontology


name: Agreement | Long term care facility | Document ontology


name: Alpha 1 antitrypsin fecal clearance panel | Serum or Plasma and Stool | Chemistry Panels


name: Alpha-1-Fetoprotein interpretation | Amniotic fluid | Chemistry - non-challenge


name: Alpha-1-Fetoprotein interpretation | Serum or Plasma | Chemistry - non-challenge


name: Amino acids intense band position | Urine | Chemistry - non-challenge


name: Anaphylaxis action plan | {Setting} | Document ontology


name: Anaplasma phagocytophilum and Ehrlichia chaffeensis IgG and IgM panel | Serum | Microbiology Panels


name: Anesthesia consent | {Setting} | Document ontology


name: Annual evaluation note | {Setting} | Document ontology


name: Annual evaluation note | Long term care facility | Document ontology


name: Annual evaluation note | Outpatient | Document ontology


name: Annual evaluation note | Patient's home | Document ontology


name: Antepartum summary note | {Setting} | Document ontology


name: APOA1 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: Area | Heart.atrium Left | Cardiac ultrasound


name: Arterial pulse intensity | Brachial artery Left | Specific heart rate


name: Arterial pulse intensity | Brachial artery Right | Specific heart rate


name: Arterial pulse intensity | Carotid artery Left | Specific heart rate


name: Arterial pulse intensity | Carotid artery Right | Specific heart rate


name: Arterial pulse intensity | Dorsal pedal artery | Specific heart rate


name: Arterial pulse intensity | Dorsal pedal artery Left | Specific heart rate


name: Arterial pulse intensity | Dorsal pedal artery Right | Specific heart rate


name: Arterial pulse intensity | Femoral artery Left | Specific heart rate


name: Arterial pulse intensity | Femoral artery Right | Specific heart rate


name: Arterial pulse intensity | Popliteal artery Left | Specific heart rate


name: Arterial pulse intensity | Popliteal artery Right | Specific heart rate


name: Arterial pulse intensity | Posterior tibial artery Left | Specific heart rate


name: Arterial pulse intensity | Posterior tibial artery Right | Specific heart rate


name: Arterial pulse intensity | Radial artery Left | Specific heart rate


name: Arterial pulse intensity | Radial artery Right | Specific heart rate


name: Arterial pulse intensity | Ulnar artery Left | Specific heart rate


name: Arterial pulse intensity | Ulnar artery Right | Specific heart rate


name: Arterial pulse intensity | XXX | General heart rate


name: Arterial pulse quality | XXX | General heart rate


name: Asthma action plan | {Setting} | Document ontology


name: Autism action plan | {Setting} | Document ontology


name: Autopsy report | {Setting} | Document ontology


name: A-wave amplitude | Heart.atrium Left | Specific venous blood pressure


name: A-wave amplitude | Heart.atrium Right | Specific venous blood pressure


name: A-wave amplitude | Pulmonary artery wedge | Specific venous blood pressure


name: Bacteria antigenic formula | Isolate | Microbiology


name: B-C slope | Pulmonic valve | Cardiac ultrasound


name: Bed state | Infant microenvironment.incubator | Neonatalology


name: Bile acid fractions panel | Serum or Plasma | Chemistry Panels


name: Birth certificate | {Setting} | Document ontology


name: Blood flow.mean | Fetus | Umbilical artery at placenta | OB ultrasound


name: Blood flow.mean | Fetus | Umbilical artery between fetus and placenta | OB ultrasound


name: Blood flow.mean | Heart ventricle Left outflow tract | OB ultrasound


name: Blood flow.mean | Heart ventricle Right outflow tract | OB ultrasound


name: Blood flow.mean | Uterine artery Left | OB ultrasound


name: Blood flow.mean | Uterine artery Right | OB ultrasound


name: Blood flow.velocity.max | Aortic valve | Cardiac ultrasound


name: Blood flow.velocity.max | Circulatory system XXX | Cardiac ultrasound


name: Blood flow.velocity.max | Heart interventricular septum defect | Cardiac ultrasound


name: Blood flow.velocity.max | Pulmonic valve | Cardiac ultrasound


name: Blood flow.velocity.max | Tricuspid valve | Cardiac ultrasound


name: Blood group antigens panel | Red Blood Cells | Blood Bank Panels


name: Blood or blood product transfusion consent | {Setting} | Document ontology


name: Body height method | XXX | General body height (length)


name: Body temperature measurement site | Patient | * | General body temperature


name: Body temperature measurement site | XXX | General body temperature


name: Breath rate method | Breath rate measurement | General respiratory


name: Breaths | Respiratory system | General respiratory


name: Breaths | Respiratory system | Specific respiratory


name: Breaths | Respiratory system | Timed specific respiratory


name: Busulfan area under the curve panel | Plasma | Drug and Toxicology Panels


name: Calcium oxalate index | Urine | Chemistry - non-challenge


name: Candida sp and Gardnerella vaginalis and Trichomonas vaginalis DNA panel | Vaginal | Microbiology Panels


name: Carbohydrate challenge panel | Exhaled gas | Challenge Bank Panels


name: Cardiac output | Heart ventricle - left | General hemodynamics


name: Cardiac output | Heart ventricle - left | Specific hemodynamics


name: Cardiac output | Heart ventricle | Specific hemodynamics


name: Cardiac output/Body surface area | Heart ventricle - left | Specific hemodynamics


name: Cardiac output/Body surface area | Heart.ventricle Right | Specific hemodynamics


name: Care management note | {Setting} | Document ontology


name: Care management note | Outpatient | Document ontology


name: Care note | {Setting} | Document ontology


name: Case report | {Setting} | Document ontology


name: Catecholamine metabolites pattern | Cerebral spinal fluid | Chemistry - non-challenge


name: Catecholamine metabolites pattern | Serum or Plasma | Chemistry - non-challenge


name: Catecholamine metabolites pattern | Urine | Chemistry - non-challenge


name: Ceramide panel | Plasma | Chemistry Panels


name: Certificate | {Setting} | Document ontology


name: Checklist | {Setting} | Document ontology


name: Checklist | Emergency department | Document ontology


name: Chlamydophila pneumoniae and Mycoplasma pneumoniae DNA panel | Lower respiratory specimen | Microbiology Panels


name: Chlamydophila pneumoniae and Mycoplasma pneumoniae DNA panel | Upper respiratory specimen | Microbiology Panels


name: Cholestane-3-beta, 5-alpha, 6-beta triol and Lyso-sphingomyelin panel | Blood | Chemistry Panels


name: Cholestane-3-beta, 5-alpha, 6-beta triol and Lyso-sphingomyelin panel | DBS | Chemistry Panels


name: Chromosome 12 copy number/nucleus | Tissue and Smears | Molecular pathology


name: Chromosome 17 copy number/nucleus | Tissue and Smears | Molecular pathology


name: Chromosome 2 copy number/nucleus | Tissue and Smears | Molecular pathology


name: Chromosome analysis | Blood or Tissue | Molecular pathology


name: Chromosome analysis.interphase | Amniotic fluid | Molecular pathology


name: Chromosome analysis.interphase | Blood | Molecular pathology


name: Chromosome analysis.interphase | Blood or Marrow | Molecular pathology


name: Chromosome analysis.interphase | Bone marrow | Molecular pathology


name: Chromosome analysis.interphase | Chorionic villus sample | Molecular pathology


name: Chromosome analysis.interphase | XXX | Molecular pathology


name: Chronic hepatitis differentiation between hepatitis B and C virus panel | Serum or Plasma | Microbiology Panels


name: Circumference | XXX | General body circumference


name: Circumference maximum | Calf Left | Specific body circumference


name: Circumference maximum | Calf Right | Specific body circumference


name: Circumference maximum | Thigh Left | Specific body circumference


name: Circumference maximum | Thigh Right | Specific body circumference


name: Circumference maximum | Whole body | Specific body circumference


name: Circumference method | XXX | General body circumference


name: Circumference site | * | General body circumference


name: Clarity | Body fluid | Specimen information


name: Communication note | {Setting} | Document ontology


name: Complement C2.functional | Serum or Plasma | Hematology and Cell counts


name: Complement C4.functional | Serum or Plasma | Hematology and Cell counts


name: Complex medical conditions action plan | {Setting} | Document ontology


name: Comprehensive history and physical note | {Setting} | Document ontology


name: Comprehensive history and physical note | Nursing facility | Document ontology


name: COMT gene product metabolic activity interpretation | Blood or Tissue | Pharmacogenomics


name: Conditions tested for in this newborn screening study | DBS | Chemistry - non-challenge


name: Conference note | {Setting} | Document ontology


name: Conference note | Long term care facility | Document ontology


name: Conference note | Nursing facility | Document ontology


name: Conference note | Patient's home | Document ontology


name: Confirmatory consultation note | {Setting} | Document ontology


name: Confirmatory consultation note | Hospital | Document ontology


name: Confirmatory consultation note | Outpatient | Document ontology


name: Conscious sedation procedure note | {Setting} | Document ontology


name: Consultation note | {Setting} | Document ontology


name: Consultation note | Adult day care center | Document ontology


name: Consultation note | Custodial care facility | Document ontology


name: Consultation note | Emergency department | Document ontology


name: Consultation note | Hospital | Document ontology


name: Consultation note | Inpatient hospital | Document ontology


name: Consultation note | Intensive care unit | Document ontology


name: Consultation note | Long term care facility | Document ontology


name: Consultation note | Outpatient | Document ontology


name: Consultation note | Outpatient hospital | Document ontology


name: Consultation note | Patient's home | Document ontology


name: Consultation note | Telehealth | Document ontology


name: Consultation note | Teleimaging | Document ontology


name: Controlled substance agreement | {Setting} | Document ontology


name: Coronary heart disease multigene analysis | Blood or Tissue | Molecular pathology


name: Cortisol post CRH stimulation panel | Serum or Plasma | Challenge Bank Panels


name: Counseling note | Custodial care facility | Document ontology


name: Counseling note | Outpatient | Document ontology


name: CPR flowsheet | {Setting} | Document ontology


name: CPR note | {Setting} | Document ontology


name: Creatinine panel | Urine | Chemistry Panels


name: Crisis intervention note | {Setting} | Document ontology


name: CYP3A4 gene product metabolic activity interpretation | Blood or Tissue | Pharmacogenomics


name: Cystic fibrosis action plan | {Setting} | Document ontology


name: Daily or end of shift signout note | {Setting} | Document ontology


name: Death certificate | {Setting} | Document ontology


name: Dermatan sulfate and heparan sulfate and keratan sulfate panel | Serum or Plasma | Chemistry Panels


name: Diabetes Type I action plan | {Setting} | Document ontology


name: Diabetes Type II action plan | {Setting} | Document ontology


name: Diagnostic study note | {Setting} | Document ontology


name: Diagnostic study note | Hospital | Document ontology


name: Diameter | Cervical canal | OB ultrasound


name: Diameter | Cervical canal external os | OB ultrasound


name: Diameter | Cervical canal internal os | OB ultrasound


name: Diameter | Fetus | Aorta | OB ultrasound


name: Diameter | Fetus | Aortic valve | OB ultrasound


name: Diameter | Fetus | Bowel | OB ultrasound


name: Diameter | Fetus | Colon lumen | OB ultrasound


name: Diameter | Fetus | Heart ventricle Left outflow tract | OB ultrasound


name: Diameter | Fetus | Heart ventricle Right outflow tract | OB ultrasound


name: Diameter | Fetus | Lung Left | OB ultrasound


name: Diameter | Fetus | Lung Right | OB ultrasound


name: Diameter | Fetus | Mitral valve | OB ultrasound


name: Diameter | Fetus | Pulmonary artery | OB ultrasound


name: Diameter | Fetus | Pulmonic valve | OB ultrasound


name: Diameter | Fetus | Renal pelvis Left | OB ultrasound


name: Diameter | Fetus | Renal pelvis Right | OB ultrasound


name: Diameter | Fetus | Right eye | OB ultrasound


name: Diameter | Fetus | Small bowel | OB ultrasound


name: Diameter | Fetus | Tricuspid valve | OB ultrasound


name: Diameter | Fetus | Umbilical vein | OB ultrasound


name: Diameter | Fetus | Urinary bladder | OB ultrasound


name: Diameter | Fetus | Yolk sac | OB ultrasound


name: Diameter | Gestational sac | OB ultrasound


name: Diameter | Heart ventricle Left outflow tract | OB ultrasound


name: Diameter | Heart ventricle Right outflow tract | OB ultrasound


name: Diameter | Pulmonary artery | OB ultrasound


name: Diameter | Pulmonic valve | Cardiac ultrasound


name: Diameter | Renal pelvis Left | OB ultrasound


name: Diameter | Renal pelvis Right | OB ultrasound


name: Diameter | Right ventricular outflow tract proximal | Cardiac ultrasound


name: Diameter.biparietal.mean | Fetus | Head | OB ultrasound


name: Diameter.biparietal/Diameter.occipital | Fetus | Head | OB ultrasound


name: Diameter.hilum-cortex | Fetus | Kidney Left | OB ultrasound


name: Diameter.hilum-cortex | Fetus | Kidney Right | OB ultrasound


name: Diameter.hilum-cortex | Kidney Left | OB ultrasound


name: Diameter.hilum-cortex | Kidney Right | OB ultrasound


name: Diameter.hilum-cortex | Ovary Left | OB ultrasound


name: Diameter.hilum-cortex | Ovary Right | OB ultrasound


name: Diameter.hilum-cortex.mean | Fetus | Kidney | OB ultrasound


name: Diameter.inner orbital | Fetus | Orbit Bilateral | OB ultrasound


name: Diameter.largest pocket.max | Fetus | Amniotic fluid space | OB ultrasound


name: Diameter.largest pocket.mean | Fetus | Amniotic fluid space | OB ultrasound


name: Diameter.long | Fetus | Kidney Left | OB ultrasound


name: Diameter.long | Fetus | Kidney Right | OB ultrasound


name: Diameter.long | Fetus | Liver | OB ultrasound


name: Diameter.long | Kidney Left | OB ultrasound


name: Diameter.long | Kidney Right | OB ultrasound


name: Diameter.long | Ovary Left | OB ultrasound


name: Diameter.long | Ovary Right | OB ultrasound


name: Diameter.long.mean | Fetus | Kidney | OB ultrasound


name: Diameter.long.mean | Fetus | Liver | OB ultrasound


name: Diameter.max | Ovary largest follicle | OB ultrasound


name: Diameter.max | Ovary Left largest follicle | OB ultrasound


name: Diameter.max | Ovary Right largest follicle | OB ultrasound


name: Diameter.mean | Fetus | Abdomen | OB ultrasound


name: Diameter.mean | Gestational sac | OB ultrasound


name: Diameter.occipito-frontal | Fetus | Head | OB ultrasound


name: Diameter.outer to outer | Fetus | Head | OB ultrasound


name: Diameter.perpendicular | Fetus | Kidney Left | OB ultrasound


name: Diameter.perpendicular | Fetus | Kidney Right | OB ultrasound


name: Diameter.perpendicular | Kidney Left | OB ultrasound


name: Diameter.perpendicular | Kidney Right | OB ultrasound


name: Diameter.perpendicular | Ovary Left | OB ultrasound


name: Diameter.perpendicular | Ovary Right | OB ultrasound


name: Diameter.perpendicular | Uterus | OB ultrasound


name: Diameter.transverse | Fetus | Abdomen | OB ultrasound


name: Diameter.transverse | Fetus | Cerebellum | OB ultrasound


name: Diameter.transverse | Fetus | Head.third cerebral ventricle | OB ultrasound


name: Diameter.transverse | Fetus | Heart | OB ultrasound


name: Diameter.transverse | Fetus | Thorax | OB ultrasound


name: Diameter.transverse | Uterus | OB ultrasound


name: Diffuse large B-Cell lymphoma cell of origin subclassification panel | Tissue and Smears | Pathology panels


name: Digitoxin>6h post dose | Serum or Plasma | Drug toxicology


name: Disability examination note | {Setting} | Document ontology


name: Discharge checklist | {Setting} | Document ontology


name: Discharge instructions | {Setting} | Document ontology


name: Discharge instructions | Emergency department | Document ontology


name: Discharge instructions | Hospital | Document ontology


name: Discharge instructions | Inpatient hospital | Document ontology


name: Discharge instructions | Urgent care center | Document ontology


name: Discharge notification note | {Setting} | Document ontology


name: Discharge notification note | Hospital | Document ontology


name: Discharge summary note | {Setting} | Document ontology


name: Discharge summary note | Adult day care center | Document ontology


name: Discharge summary note | Custodial care facility | Document ontology


name: Discharge summary note | Emergency department | Document ontology


name: Discharge summary note | Hospital | Document ontology


name: Discharge summary note | Intensive care unit | Document ontology


name: Discharge summary note | Long term care facility | Document ontology


name: Discharge summary note | Observation unit | Document ontology


name: Discharge summary note | Outpatient | Document ontology


name: Discharge summary note | Outpatient hospital | Document ontology


name: Discharge summary note | Patient's home | Document ontology


name: Discharge summary note | Recovery room | Document ontology


name: Discharge teaching note | {Setting} | Document ontology


name: Discharge teaching note | Emergency department | Document ontology


name: Discharge teaching note | Hospital | Document ontology


name: Discharge teaching note | Patient's home | Document ontology


name: Disease staging note | {Setting} | Document ontology


name: Driver license | {Setting} | Document ontology


name: Education note | {Setting} | Document ontology


name: Education note | Custodial care facility | Document ontology


name: Education note | Emergency department | Document ontology


name: Education note | Hospital | Document ontology


name: Education note | Long term care facility | Document ontology


name: Education note | Outpatient | Document ontology


name: Education note | Patient's home | Document ontology


name: Education note | Telehealth | Document ontology


name: Ehlers-Danlos syndrome multigene analysis | Blood or Tissue | Molecular pathology


name: Ejection time | Heart ventricle - left | Specific hemodynamics


name: Emergency procedure note | {Setting} | Document ontology


name: End-diastolic volume | Heart ventricle - left | Specific hemodynamics


name: End-diastolic volume | Heart.ventricle Right | Specific hemodynamics


name: End-systolic volume | Heart ventricle - left | Specific hemodynamics


name: End-systolic volume | Heart.ventricle Right | Specific hemodynamics


name: Epstein Barr virus Ab panel | Donor | Serum | Microbiology Panels


name: Ethyl sulfate and Ethyl glucuronide panel | Urine | Drug and Toxicology Panels


name: Evaluation + Plan note | {Setting} | Document ontology


name: Evaluation and management | {Setting} | Document ontology


name: Evaluation and management | Hospital | Document ontology


name: Evaluation and management consent | {Setting} | Document ontology


name: Evaluation and management of anticoagulation note | {Setting} | Document ontology


name: Evaluation and management of anticoagulation note | Outpatient | Document ontology


name: Evaluation and management of hyperlipidemia note | {Setting} | Document ontology


name: Evaluation and management of hyperlipidemia note | Outpatient | Document ontology


name: Evaluation and management of hypertension note | {Setting} | Document ontology


name: Evaluation and management of radiation exposure note | {Setting} | Document ontology


name: Evaluation and management of smoking cessation note | {Setting} | Document ontology


name: Evaluation and management of smoking cessation note | Hospital | Document ontology


name: Evaluation and management of smoking cessation note | Outpatient | Document ontology